Bionovate Technologies Corp (BIIO)
Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely target and treat these blemishes on any area of the body. The firm plans to distribute these advanced systems globally, marketing them to healthcare providers and wellness centers. Founded in Cham, Switzerland, in 2010, the organization previously traded under the name MJP International Ltd. before adopting Bionovate Technologies Corp. in December 2017. Since October 7, 2020, the company has operated as an affiliated entity of Human Data AG.
Sector: Medical - Devices
Industry: Medical - Devices
Bionovate Technologies Corp
- 0.0%
- 51
- 51.00
Float 3.95M · FMP free float
The cost to borrow BIIO shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- No fails on record for 16–31 Oct 2026.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 51 sh |
| Oct 15, 2026 | 51 sh |
| Sep 30, 2026 | 51 sh |
| Sep 15, 2026 | 51 sh |
| Aug 31, 2026 | 51 sh |
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
FINRA publishes no off-exchange short volume for this symbol.
FINRA's weekly alternative trading system (dark pool) volume for BIIO: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 51 BIIO shares were sold short (<0.01% of a 3.95M-share float, 51.00 days to cover).